Literature DB >> 8506943

Expression of interleukin-2R alpha and interleukin-2R beta in Hodgkin's disease.

H Tesch1, A Günther, H Abts, M Jücker, S Klein, G R Krueger, V Diehl.   

Abstract

Hodgkin and Reed-Sternberg cells, the putative malignant cells of Hodgkin's disease (HD), carry regularly the CD25 antigen that forms one chain of the interleukin-2 (IL-2) receptor (IL-2R alpha). To analyze the putative role of IL-2R expression in Hodgkin's disease, we have investigated the expression of both IL-2R alpha and IL-2R beta chains in HD-derived cell lines and in primary specimens from patients with HD. Expression of IL-2R alpha and IL-2R beta was detected in all HD-derived cell lines. In addition, soluble IL-2R alpha molecules were demonstrated in the supernatants of three of these cultured cell lines. In primary tissues, IL-2R alpha and IL-2R beta were seen in some but not all cases. Staining was detected in Hodgkin and Reed-Sternberg and in lymphoid cells. There was a remarkable difference in the pattern of expression, in that IL-2R alpha- but not IL-2R beta-positive cells from HD patients were clustered in frozen sections. We conclude from these data that IL-2R expression might be involved in the biology of HD.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8506943      PMCID: PMC1886973     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  23 in total

1.  Expression of Tac antigen in B cell lymphomas.

Authors:  G Laurent; T Al Saati; D Olive; J C Laurent; P Poncelet; G Delsol
Journal:  Clin Exp Immunol       Date:  1986-08       Impact factor: 4.330

2.  Immunoglobulin gene rearrangements in Hodgkin's disease.

Authors:  L M Weiss; J G Strickler; E Hu; R A Warnke; J Sklar
Journal:  Hum Pathol       Date:  1986-10       Impact factor: 3.466

3.  Monoclonal antibodies defining distinct epitopes of the human IL-2 receptor beta chain and their differential effects on IL-2 responses.

Authors:  K Ohbo; T Takeshita; H Asao; Y Kurahayashi; K Tada; H Mori; M Hatakeyama; T Taniguchi; K Sugamura
Journal:  J Immunol Methods       Date:  1991-08-28       Impact factor: 2.303

4.  IL-2 receptor expression in human lymphoid lesions. Immunohistochemical study of 166 cases.

Authors:  J A Strauchen; B A Breakstone
Journal:  Am J Pathol       Date:  1987-03       Impact factor: 4.307

5.  Characteristics of Hodgkin's disease-derived cell lines.

Authors:  V Diehl; H H Kirchner; H Burrichter; H Stein; C Fonatsch; J Gerdes; M Schaadt; W Heit; B Uchanska-Ziegler; A Ziegler; F Heintz; K Sueno
Journal:  Cancer Treat Rep       Date:  1982-04

6.  The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells.

Authors:  H Stein; D Y Mason; J Gerdes; N O'Connor; J Wainscoat; G Pallesen; K Gatter; B Falini; G Delsol; H Lemke
Journal:  Blood       Date:  1985-10       Impact factor: 22.113

7.  Interleukin 2 receptor gene expression in normal human T lymphocytes.

Authors:  W J Leonard; M Krönke; N J Peffer; J M Depper; W C Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

8.  Rearrangement of the beta chain of the T cell antigen receptor and immunoglobulin genes in lymphoproliferative disorders.

Authors:  H Griesser; A Feller; K Lennert; M Minden; T W Mak
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

9.  Autocrine growth of interleukin 2-producing leukemic cells in a patient with adult T cell leukemia.

Authors:  N Arima; Y Daitoku; S Ohgaki; J Fukumori; H Tanaka; Y Yamamoto; K Fujimoto; K Onoue
Journal:  Blood       Date:  1986-09       Impact factor: 22.113

10.  Reconstitution of functional receptor for human interleukin-2 in mouse cells.

Authors:  M Hatakeyama; S Minamoto; T Uchiyama; R R Hardy; G Yamada; T Taniguchi
Journal:  Nature       Date:  1985 Dec 5-11       Impact factor: 49.962

View more
  5 in total

1.  Human herpesvirus 6 and Epstein-Barr virus in Hodgkin's disease: a controlled study by polymerase chain reaction and in situ hybridization.

Authors:  G Valente; P Secchiero; P Lusso; M C Abete; C Jemma; G Reato; S Kerim; R C Gallo; G Palestro
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

2.  Expression of epstein-barr virus nuclear antigen 1 is associated with enhanced expression of CD25 in the Hodgkin cell line L428.

Authors:  D Kube; M Vockerodt; O Weber; K Hell; J Wolf; B Haier; F A Grässer; N Müller-Lantzsch; E Kieff; V Diehl; H Tesch
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

Review 3.  Receptor-directed therapy of T-cell leukemias and lymphomas.

Authors:  John C Morris; Thomas A Waldmann; John E Janik
Journal:  J Immunotoxicol       Date:  2008-04       Impact factor: 3.000

4.  Presence of human herpes virus 6 (HHV6) in pediatric lymphomas: impact on clinical course and association with cytomegalovirus infection.

Authors:  Samah A Loutfy; Mohamed Fawzy; Mohamed El-Wakil; Manar M Moneer
Journal:  Virol J       Date:  2010-10-27       Impact factor: 4.099

5.  Clinical and histopathological evaluation of 16 dogs with T-zone lymphoma.

Authors:  Noriyuki Mizutani; Yuko Goto-Koshino; Masashi Takahashi; Kazuyuki Uchida; Hajime Tsujimoto
Journal:  J Vet Med Sci       Date:  2016-04-21       Impact factor: 1.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.